Antares Pharma: 2Q Earnings Snapshot
Aug. 07, 2018
EWING, N.J. (AP) _ Antares Pharma Inc. (ATRS) on Tuesday reported a loss of $4.5 million in its second quarter.
On a per-share basis, the Ewing, New Jersey-based company said it had a loss of 3 cents.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.
The drugmaker posted revenue of $14.2 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $13.7 million.
The company's shares closed at $2.89. A year ago, they were trading at $3.12.